Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Cell Lines01:16

Cell Lines

10.0K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
10.0K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Automated Flow Cytometry Data Analysis Tools within Cell and Gene Therapy Manufacturing.

International journal of molecular sciences·2022
Same author

Systematic Design, Generation, and Application of Synthetic Datasets for Flow Cytometry.

PDA journal of pharmaceutical science and technology·2022
Same author

Assessment of Protocol Impact on Subjectivity Uncertainty When Analyzing Peripheral Blood Mononuclear Cell Flow Cytometry Data Files.

Methods and protocols·2021
Same author

Current trends in flow cytometry automated data analysis software.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2021
Same author

Quantifying Operator Subjectivity within Flow Cytometry Data Analysis as a Source of Measurement Uncertainty and the Impact of Experience on Results.

PDA journal of pharmaceutical science and technology·2020
Same author

Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds.

Scientific reports·2018

Related Experiment Video

Updated: Jan 14, 2026

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

940

The Developing Standards Landscape for Cell and Gene Therapies.

Jonathan J Campbell1, Julian H Braybrook2

  • 1MetBio Scientific Consulting, Market Deeping, UK. jonathan.campbell@metbio.co.uk.

Advances in Experimental Medicine and Biology
|October 24, 2025
PubMed
Summary

Standardization is crucial for advancing complex technologies like cell and gene therapies. This work outlines drivers, stakeholders, and governance for developing standards to ensure product consistency and regulatory approval.

Keywords:
CharacterizationCritical process parametersCritical quality attributesDocumentary standardsHarmonizationMetrologyQualityReference materialsReference methodsStandardization

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.6K
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

4.9K

Related Experiment Videos

Last Updated: Jan 14, 2026

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

940
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.6K
Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
09:44

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers

Published on: July 7, 2023

4.9K

Area of Science:

  • Biotechnology
  • Regulatory Science
  • Pharmaceutical Manufacturing

Background:

  • Cell and gene therapies represent a new class of 'living drugs' requiring robust development and adoption strategies.
  • The rapid advancement of these therapies presents complex challenges in standardization due to interdisciplinary needs and scalable production.

Purpose of the Study:

  • To introduce and develop key drivers for standardization in the cell and gene therapy sector.
  • To identify stakeholders involved in standardization efforts.
  • To outline governance structures essential for standards development and deployment.

Main Methods:

  • Literature review and analysis of current standardization practices.
  • Stakeholder analysis within the cell and gene therapy ecosystem.
  • Framework development for governance structures.

Main Results:

  • Identified critical drivers for standardization, including interdisciplinary expertise, system interconnectivity, and scalable manufacturing.
  • Outlined the roles of diverse stakeholders (e.g., researchers, manufacturers, regulators).
  • Proposed governance models to facilitate standards development and implementation.

Conclusions:

  • Effective standardization is vital for overcoming challenges in product/process characterization, manufacturing consistency, and regulatory approval for cell and gene therapies.
  • A structured approach involving clear drivers, stakeholder engagement, and robust governance is necessary for successful standardization.
  • Implementing these strategies will accelerate the development and adoption of these life-saving therapies.